Adrenal Gland Pheochromocytoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
416
|
50
|
0.200 |
None |
0.974 |
117 |
|
2001 |
2020 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.200 |
None |
0.954 |
108 |
|
2002 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.976 |
41 |
|
2003 |
2020 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.973 |
37 |
|
2003 |
2020 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
1.000 |
14 |
|
2001 |
2019 |
Von Hippel-Lindau Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
174
|
187
|
0.100 |
None |
0.846 |
13 |
|
2003 |
2012 |
hereditary paraganglioma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
15
|
1
|
0.400 |
strong |
0.909 |
11 |
|
2001 |
2014 |
Familial (FPAH)
|
disease |
|
Disease or Syndrome
|
1075
|
276
|
0.100 |
None |
0.900 |
10 |
|
2002 |
2018 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.090 |
None |
0.556 |
9 |
|
2008 |
2019 |
Neurofibromatosis 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
311
|
827
|
0.080 |
None |
1.000 |
8 |
|
2003 |
2017 |
Kidney Neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
295
|
11
|
0.060 |
None |
1.000 |
6 |
|
2004 |
2015 |
Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2509
|
386
|
0.060 |
None |
0.833 |
6 |
|
2004 |
2016 |
Central neuroblastoma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
2419
|
231
|
0.050 |
None |
0.800 |
5 |
|
2004 |
2016 |
Pheochromocytoma, Extra-Adrenal
|
disease |
Neoplasms
|
Neoplastic Process
|
38
|
5
|
0.450 |
None |
1.000 |
5 |
|
2005 |
2008 |
Malignant neoplasm of kidney
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
664
|
22
|
0.350 |
strong |
1.000 |
5 |
|
2004 |
2017 |
Mitochondrial Diseases
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
284
|
84
|
0.340 |
None |
1.000 |
5 |
|
2012 |
2019 |
Childhood Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2420
|
231
|
0.050 |
None |
0.800 |
5 |
|
2004 |
2016 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.040 |
None |
0.750 |
4 |
|
2010 |
2019 |
metastatic pheochromocytoma
|
disease |
|
Neoplastic Process
|
8
|
|
0.040 |
None |
1.000 |
4 |
|
2008 |
2020 |
Pheochromocytoma, malignant
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
11
|
1
|
0.040 |
None |
1.000 |
4 |
|
2006 |
2014 |
Renal carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
665
|
21
|
0.040 |
None |
1.000 |
4 |
|
2012 |
2017 |
Metastatic Adrenal Gland Pheochromocytoma
|
disease |
|
Neoplastic Process
|
8
|
|
0.040 |
None |
1.000 |
4 |
|
2008 |
2020 |
Thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1175
|
145
|
0.030 |
None |
1.000 |
3 |
|
2004 |
2015 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
61
|
59
|
0.030 |
None |
1.000 |
3 |
|
2007 |
2018 |
Mitochondrial Complex II Deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
8
|
45
|
0.330 |
None |
1.000 |
3 |
|
2005 |
2015 |